Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares declined 8.98 percent to close at $5.27 a share Monday. The stock traded between $5.06 and $5.52 on volume of 11.37 million shares traded. Credit Suisse analyst Lee Kalowski has lowered his price target on the company to $4.00 from $5.00. Shares of Arena Pharmaceuticals have fallen approximately 41.0 percent year-to-date.
Get more information on Arena Pharmaceuticals and free access to the in-depth equity report at:
ArQule, Inc. (NASDAQ: ARQL) shares dropped 9.34 percent to close at $2.33 a share Monday. The stock traded between $2.31 and $2.65 on volume of 1.73 million shares traded. The company recently presented data at the European Cancer Congress that "demonstrated clinical benefits of treatment with the combination of tivantinib and erlotinib in patients with non-squamous, non-small cell lung cancer."
Get more information on ArQule and free access to the in-depth equity report at:
Frontier Communications Corp. (NASDAQ: FTR) shares declined 2.56 percent to close at $4.18 a share Monday. The stock traded between $4.09 and $4.32 on volume of 22.06 million shares traded. The company is laying off 54 employees its Carmel collection center. Shares of Frontier Communications have fallen approximately 2.3 percent year-to-date.
Get more information on Frontier Communications free access to the in-depth equity report at:
China Ming Yang Wind Power Group Ltd. (NYSE: MY) shares spiked 11.16 percent to close at $2.39 a share Monday. The stock traded between $2.03 and $2.66 on volume of 5.66 million shares traded. The company announced that it "has secured a total of 87MW in the first tranche of tender for off-shore wind power near Zhuhai Guishan Island". Shares of Ming Yang have gained approximately 100.0 percent year-to-date.
Get more information on Ming Yang and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...